Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention

VD Vidi, ME Matheny, V Agarwal, N Arora… - The American journal of …, 2010 - Elsevier
Randomized controlled trials have shown improved short-term bleeding outcomes for
bivalirudin compared to unfractionated heparin (UFH) in patients undergoing percutaneous …
被引用次数：12 相关文章

[引用][C] Validation of Long-Term Benefits of Bivalirudin Versus Unfractionated Heparin in Routine Clinical Practice After Percutaneous Coronary Intervention

VD VIDI, ME MATHENY, V AGARWAL… - … American journal of …, 2010 - pascal-francis.inist.fr
Validation of Long-Term Benefits of Bivalirudin Versus Unfractionated Heparin in Routine Clinical
Practice After Percutaneous Coronary Intervention CNRS Inist Pascal-Francis CNRS Pascal and …

[引用][C] Validation of Long-Term Benefits of Bivalirudin Versus Unfractionated Heparin in Routine Clinical Practice After Percutaneous Coronary Intervention

VD Vidi, ME Matheny, V Agarwal, N Arora… - The American Journal …, 2010 - cir.nii.ac.jp
Validation of Long-Term Benefits of Bivalirudin Versus Unfractionated Heparin in Routine
Clinical Practice After Percutaneous Coronary Intervention | CiNii Research CiNii 国立情報学 …

Validation of Long-Term Benefits of Bivalirudin Versus Unfractionated Heparin in Routine Clinical Practice After Percutaneous Coronary Intervention

VD Vidi, ME Matheny, V Agarwal, N Arora… - American Journal of …, 2010 - ajconline.org
Randomized controlled trials have shown improved short-term bleeding outcomes for
bivalirudin compared to unfractionated heparin (UFH) in patients undergoing percutaneous …

Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention

VD Vidi, ME Matheny, V Agarwal… - The American …, 2010 - pubmed.ncbi.nlm.nih.gov
Randomized controlled trials have shown improved short-term bleeding outcomes for
bivalirudin compared to unfractionated heparin (UFH) in patients undergoing percutaneous …
[HTML] nih.gov

[HTML][HTML] Validation of Long-term Benefits of Bivalirudin vs. Unfractionated Heparin in Routine Clinical Practice after Percutaneous Coronary Intervention

VD Vidi, ME Matheny, V Agarwal, N Arora… - The American journal …, 2010 - ncbi.nlm.nih.gov
Randomized controlled trials have shown improved short-term bleeding outcomes for
bivalirudin relative to unfractionated heparin (UFH) in patients undergoing percutaneous …

Validation of Long-Term Benefits of Bivalirudin Versus Unfractionated Heparin in Routine Clinical Practice After Percutaneous Coronary Intervention

VD Vidi, ME Matheny, V Agarwal, N Arora… - The American Journal of …, 2010 - infona.pl
Randomized controlled trials have shown improved short-term bleeding outcomes for
bivalirudin compared to unfractionated heparin (UFH) in patients undergoing percutaneous …

Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention.

VD Vidi, ME Matheny, V Agarwal, N Arora… - The American Journal …, 2010 - europepmc.org
Randomized controlled trials have shown improved short-term bleeding outcomes for
bivalirudin relative to unfractionated heparin (UFH) in patients undergoing percutaneous …

Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention.

VD Vidi, ME Matheny, V Agarwal, N Arora… - The American Journal …, 2010 - europepmc.org
Randomized controlled trials have shown improved short-term bleeding outcomes for
bivalirudin compared to unfractionated heparin (UFH) in patients undergoing percutaneous …

[引用][C] Validation of Long-Term Benefits of Bivalirudin Versus Unfractionated Heparin in Routine Clinical Practice After Percutaneous Coronary Intervention

VD VIDI, ME MATHENY, V AGARWAL… - The American journal of …, 2010 - Elsevier